Lupus & Connective Tissue Diseases
Feature
Doctors urge screening for autoimmune disorders for patients with celiac disease
At least in some cases, people with one autoimmune disorder should be tested for others, celiac disease specialists say.
Conference Coverage
Combination therapy shows mixed results for scleroderma-related lung disease
A study of mycophenolate mofetil alone and in combination with pirfenidone for scleroderma-related interstitial lung disease showed mixed results...
Conference Coverage
Lower hydroxychloroquine dose for lupus tied to hospitalizations for flares
Longer-term HCQ-induced retinopathy risk must be balanced with shorter-term risk for hospitalization for an SLE flare from a lower dose,...
Conference Coverage
Remibrutinib safe for Sjögren’s in phase 2
Results show the Bruton tyrosine kinase inhibitor has potential to become the first effective oral disease-modifying therapy for Sjögren syndrome...
Conference Coverage
Rituximab ‘a reasonable alternative to cyclophosphamide’ to improve ILD-CTD
A clinical trial found that rituximab and cyclophosphamide had similar outcomes for interstitial lung disease associated with connective tissue...
Conference Coverage
Clinical signs differ between children and adults with vasculitis
Many pediatric rheumatologists believe kids with vasculitis are like small adults and should be treated similarly, but Dr. Jessica Bloom said the...
Guidelines
First recommendations for cancer screening in myositis issued
The guideline, based on data from a systematic review and meta-analysis and on consensus from an international team of experts and patients,...
Commentary
Rheumatic diseases and assisted reproductive technology: Things to consider
Dr. Karmela Kim Chan and Dr. Caroline H. Siegel give an update on what’s known about the use of assisted reproductive technology in patients with...
From the Journals
Metabolites may distinguish severe subtypes of PAH
Patients with the systemic sclerosis subtype of pulmonary arterial hypertension showed a distinctive bioactive lipid signature
From the Journals
IVIG proves effective for dermatomyositis in phase 3 trial
Prior to this trial, intravenous immune globulin had not been fully studied for the treatment of dermatomyositis.
From the Journals
Evusheld PrEP may protect immunocompromised patients from severe COVID-19
Evusheld preexposure prophylaxis shows promise in protecting certain immunocompromised patients from severe COVID-19, Cleveland Clinic researchers...